S. Bertholet

Publications80
h-index37
Citations5,118
Highly Influential Citations181
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • S. Reed
  • 505 Publications, 27,143 Citations
  • R. Rappuoli
  • 756 Publications, 48,176 Citations
  • E. de Gregorio
  • 53 Publications, 4,798 Citations
  • R. Coler
  • 132 Publications, 6,466 Citations
  • Publications
  • Influence
New horizons in adjuvants for vaccine development.
Over the last decade, there has been a flurry of research on adjuvants for vaccines, and several novel adjuvants are now in licensed products or in late stage clinical development. The success of… Expand
  • 574
  • 31
  • PDF
Phagosomes are competent organelles for antigen cross-presentation
The ability to process microbial antigens and present them at the surface of cells is an important aspect of our innate ability to clear infections. It is generally accepted that antigens in the… Expand
  • 721
  • 26
Programmed cell death in the unicellular protozoan parasite Leishmania
In the present study we have demonstrated some features characterizing programmed cell death (PCD) in the unicellular protozoan parasite Leishmania donovani, the causative agent of visceral… Expand
  • 251
  • 19
Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
Innate immune responses to vaccine adjuvants based on lipopolysaccharide (LPS), a component of Gram-negative bacterial cell walls, are driven by Toll-like receptor (TLR) 4 and adaptor proteins… Expand
  • 235
  • 12
  • PDF
A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosis
A vaccine with a four-protein fusion peptide from Mycobacterium tuberculosis effectively boosts the current childhood TB vaccine and protects against drug-resistant TB. A Superior Shot for… Expand
  • 233
  • 12
CD8+ T Cells Are Required for Primary Immunity in C57BL/6 Mice Following Low-Dose, Intradermal Challenge with Leishmania major
Standard murine models of cutaneous leishmaniasis, involving s.c. inoculation of large numbers of Leishmania major promastigotes, have not supported an essential role for CD8+ T cells in the control… Expand
  • 260
  • 8
Leishmania major Low-Dose , Intradermal Challenge with Immunity in C 57 BL / 6 Mice Following T Cells Are Required for Primary + CD 8 and
  • 44
  • 8
  • PDF
Programmed cell death in trypanosomatids and other unicellular organisms.
In multicellular organisms, cellular growth and development can be controlled by programmed cell death (PCD), which is defined by a sequence of regulated events. However, PCD is thought to have… Expand
  • 150
  • 7
Identification of Human T Cell Antigens for the Development of Vaccines against Mycobacterium tuberculosis1
Development of a subunit vaccine for Mycobacterium tuberculosis (Mtb) depends on the identification of Ags that induce appropriate T cell responses. Using bioinformatics, we selected a panel of 94… Expand
  • 126
  • 7
Conditions Influencing the Efficacy of Vaccination with Live Organisms against Leishmania major Infection
ABSTRACT Numerous experimental vaccines have been developed with the goal of generating long-term cell-mediated immunity to the obligate intracellular parasite Leishmania major, yet inoculation with… Expand
  • 84
  • 6
  • PDF